Readers Speak Up About Women’s Health Issues, From Reproductive Care to Drinking
KFF Health News gives readers a chance to comment on a recent batch of stories.
The independent source for health policy research, polling, and news.
321 - 340 of 971 Results
KFF Health News gives readers a chance to comment on a recent batch of stories.
After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country. This decreases patient choice, impedes innovation, erodes quality of care, and raises prices. And federal regulators have been slow to act.
The federal government’s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.
Dec. 15 is the deadline to sign up for Affordable Care Act plans that begin Jan. 1, and Congress remains at odds over letting expanded tax credits for the plans’ premiums expire and increasing the cost of insurance for millions of Americans. Meanwhile, HHS Secretary Robert F. Kennedy Jr. continues to remake vaccine policy to reflect ideology rather than science. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sheryl Gay Stolberg of The New York Times join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Georgetown professor Linda Blumberg about the GOP’s health plans.
Ballad Health, the only hospital system across a large swath of Tennessee and Virginia, has fallen short of quality-of-care and charity care obligations — even as it’s sued thousands of patients for unpaid bills.
Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
Consumers should know that this type of fraud can happen, whether from a large-scale breach or theft of an individual’s data. The result could be thousands of dollars in medical bills.
New Hampshire voters have spoken, and it seems increasingly clear that this November’s election will pit President Joe Biden against former President Donald Trump. Both appear to be making health a key part of their campaigns, with Trump vowing (again) to repeal the Affordable Care Act, and Biden stressing his support for contraception and abortion rights. Meanwhile, both candidates will try to highlight efforts to rein in prescription drug prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Jessie Hellmann of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Sarah Somers of the National Health Law Program about the potential consequences for the health care system if the Supreme Court overturns a key precedent attempting to balance executive vs. judicial power.
A Wisconsin lawsuit alleges United Healthcare downplayed abusive sales tactics to avoid losing government bonuses.
New research shows that older adults want close relationships with the people they care about and meaningful social roles.
A talking point used by House Speaker Nancy Pelosi refers to all three of these distinct concepts in a way that could magnify public misperceptions.
What does a law to protect worker pensions have to do with how health insurance is regulated? Far more than most people may think. The Employee Retirement Income Security Act, or ERISA, turns 50 in September. The law fundamentally changed the way the federal and state governments regulate employer-provided health insurance and continues to shape health policy in the United States. In this special episode of “What the Health?”, host and KFF Health News chief Washington correspondent Julie Rovner speaks to Larry Levitt of KFF, Paul Fronstin of the Employee Benefit Research Institute, and Ilyse Schuman of the American Benefits Council about the history of ERISA and what its future might hold.
Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law — and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of KFF Health News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week’s Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
The House finally has a new speaker: Mike Johnson (R-La). He’s a relative newcomer who’s been a lower-level member of the House GOP leadership. And while he’s an outspoken opponent of abortion and same-sex marriage, his record on other health issues is scant. Meanwhile, the National Institutes of Health appears on track to be getting a new director, and Georgia’s Medicaid work requirement experiment is off to a very slow start. Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank.
Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?
Some Supreme Court justices were wrong if they assumed overturning "Roe v. Wade" would settle the abortion issue before the high court. At least two cases are awaiting consideration, and more are in the legal pipeline. Meanwhile, Congress once again has only days until the next temporary spending bill runs out, with no budget deal in sight. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Victoria Knight of Axios join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Sandro Galea, dean of the Boston University School of Public Health, about how public health can regain public trust.
The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
“Medicare for America” seeks to avoid some of the predictable obstacles of a full-blown expansion of Medicare. Can it survive the politics of health reform?
Congress returns from its summer recess with a long list of tasks and only a few work days to get them done. On top of the annual spending bills needed to keep the government operating, on the list are bills to renew the global HIV/AIDS program, PEPFAR, and the community health centers program. Meanwhile, over the recess, the Biden administration released the names of the first 10 drugs selected for the Medicare price negotiation program.
Medicare doesn’t pay for an annual physical, but it does cover an annual wellness visit focused on preventing disease and disability by coming up with a “personalized prevention plan” for future medical issues. It is important to use the correct term when scheduling a doctor’s visit.
© 2026 KFF